<?xml version="1.0" encoding="UTF-8"?>
<p>The hypothesis that waning immunity is a cause of global resurgence in mumps cases suggests administration of an additional dose of vaccine during adolescence [
 <xref rid="B77-ijerph-17-01686" ref-type="bibr">77</xref>,
 <xref rid="B124-ijerph-17-01686" ref-type="bibr">124</xref>]. Between 2016 and 2017, there are numerous mumps outbreaks occurred throughout United States. To reflex these urgent events, the Advisory Committee on Immunization Practices (ACIP) recommended a third dose of MMR vaccine for groups of persons justified by public health authorities at increased risk for acquiring mumps due to an outbreak of mumps [
 <xref rid="B5-ijerph-17-01686" ref-type="bibr">5</xref>]. Subsequently, a guidance was developed by the Centers for Disease Control (CDC) and Prevention in the US to assist public health authorities when making decisions that effect groups at risk of acquiring mumps. Such groups should receive a third dose of the mumps vaccine. Based on the CDC guidance, public health authorities may opt to use when considering a third dose of MMR for controlling mumps outbreak [
 <xref rid="B5-ijerph-17-01686" ref-type="bibr">5</xref>].
</p>
